Enrolling Clinical Research Studies with Nephrology Associates

Therapeutic Areas:
*FSGS- Research study for adults with CKD Stages 1 through 3A and newly diagnosed primary FSGS (Focal Segmental Glomerulosclerosis) that have not began steroid treatment.
*Uncontrolled Hypertension- Research study for adults with CKD Stages 3B through 4 and uncontrolled high blood pressure currently taking at least 2 blood pressure medications.
*IgA Nephropathy- Research study for adults with CKD Stages 1 through 3A diagnosed with primary IgA Nephropathy within 5 years at risk for developing end-stage kidney disease. Subject must be on ACEIs or ARBs therapy.

*Anemia- Multiple research studies for adults with CKD Stages 3 through 5 and anemia at risk for end-stage kidney disease. Study involves oral and injectable medication to potentially decrease fatigue associated with anemia and increase hemoglobin levels. Must not be on dialysis or planning to start dialysis within 6 months.

*Metabolic Acidosis- Research study for adults with CKD Stages 3B through 4, non-dialysis dependent, and with a serum bicarbonate level between 12-20. Study involves an investigational oral drug that binds acid in the digestive tract without increasing sodium load, as sodium bicarbonate supplements do, to treat metabolic acidosis in order to possibly slow the progression of CKD.

Additional Information:
*Some studies may offer compensation for participation
*Some studies provide transportation to and from study site
*Close monitoring from qualified research staff while enrolled on study

Anyone interested should consult their nephrology to see if one of these studies would be appropriate for you.

If interested in learning more, contact:
Nephrology Associates Clinical Research Department
28 White Bridge Road, Ste. 300
Nashville, TN. 37205
Phone: 615-354-2408
Email: research@tnkidney.com

Leave a Reply

Your email address will not be published.

Post comment